bezafibrate has been researched along with Huntington Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Brondani, M; de Medeiros, MP; Hoffmann, CIH; Leipnitz, G; Ribeiro, RT; Roginski, AC; Seminotti, B; Wajner, M | 1 |
Beal, MF; Calingasan, NY; Chandra, A; Johri, A; Sharma, A; Shurubor, Y; White, JM; Yang, XW | 1 |
Beal, MF; Calingasan, NY; Chandra, A; Hennessey, TM; Johri, A; Sharma, A; Wille, E; Yang, L | 1 |
3 other study(ies) available for bezafibrate and Huntington Disease
Article | Year |
---|---|
Mitochondrial dysfunction, oxidative stress, ER stress and mitochondria-ER crosstalk alterations in a chemical rat model of Huntington's disease: Potential benefits of bezafibrate.
Topics: Animals; Bezafibrate; Glutathione; Huntington Disease; Mitochondria; Models, Chemical; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Superoxide Dismutase; Synaptophysin | 2023 |
Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.
Topics: Animals; Bezafibrate; Corpus Striatum; Disease Models, Animal; Humans; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Mitochondria; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR delta; PPAR gamma; Signal Transduction | 2016 |
Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease.
Topics: Adipose Tissue, Brown; Animals; Bezafibrate; Corpus Striatum; Diet; Disease Models, Animal; Gliosis; Huntington Disease; Mice; Mice, Transgenic; Mitochondria; Mitochondria, Muscle; Muscle Fibers, Skeletal; Neurons; Neuroprotective Agents; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenotype; PPAR gamma; Signal Transduction; Survival Rate; Trans-Activators; Transcription Factors; Transcriptional Activation; Vacuoles | 2012 |